Abstract:Abstract BACKGROUND Up to 17% of distal ulcerative colitis (UC) patients have discontinuous (proximal) inflammation referred to as Cecal Patch (CP), associated with greater abdominal pain, bleeding and diarrhea. Despite these known associations, the pathogenesis of CP lesions is poorly understood. Recent data suggest that reduced mitochondrial (Mito) function predicts unfavorable clinical outcomes in active UC (Haberman et al; Nat Comm 2019). We posit that inflammation and tissue injury induced in UC-associated CP involves Mito dysfunction. METHOD UC patients with/without cecal disease and normal controls were biopsied. Tissue from CP lesions or normal caecum were collected in Allprotect® (AP) and formalin. Total RNA from AP-preserved biopsies were used for cDNA synthesis and RT-qPCR for Mito complexes, cytokines, anti-oxidant and calcineurin (CaN) signaling genes and tissue processed for IHC for Mito complexes. RESULT Transcriptomic analysis showed significant downregulation in genes associated with Mito biogenesis (PGC1α, TFAM, NRF2) and Mito complexes (Ndufa1, Ndufa4, Ndufb2, Ndufb6, mtCO1, mtCO2, Cox5B, Cox6A1, ATP5A1, ATP5B, ATP5E) in CP lesions compared to normal caecum from active patients. Major regulators of Mito biogenesis (PGC1α and TFAM) revealed ~39% and ~24% reductions of mRNA respectively, while NRF2 (anti-oxidant regulator) showed ~62% reduced mRNA in CP lesions compared to normal cecum from distal UC patients. Electron transport chain complex mRNAs showed 31%, 47%, and 48% reduction in complex I (Ndufa1, Ndufa4, Ndufb2, Ndufb6), complex IV (mtCO1, mtCO2, Cox5B, Cox6A1), and complex V (ATP5A1, ATP5B, ATP5E) levels, respectively in CP lesions compared to normal controls. Concomitantly, the IHC staining also showed significant reductions in Ndufb6, MTCO1 and Cox5A protein levels in CP lesions compared to normal cecum sections. The CP-related decreased markers of Mito biogenesis and function correlates with increased proinflammatory cytokine mRNA (IL-6: 2-fold; TGFβ1: 1.6-fold; IL-2: 2.6-fold) and decreased anti-inflammatory (IL10: 3.2-fold) gene expression in CP lesions. Further investigation demonstrated that repressed Mito function in CP lesions is associated with downregulation of anti-oxidant genes (SOD1, SOD2, Prdx3, Gpx4, Trx2) compared to normal cecum. Inflammation-induced Mito dysfunction in CP lesions also stimulates CaN signaling as demonstrated by significant increases in mRNA levels of CaN and downstream regulated genes (Cathepsin-L, Rel-A Glut4, CREB-BP and Igf-1r). CONCLUSION These data represent the first indication that Mito dysfunction occurs in CP associated with distal UC. Furthermore, we speculate that Mito dysfunction-induced CaN signaling promotes regional (CP) inflammatory responses. These important findings indicate that targeting Mito metabolism may be an important therapeutic goal of treating UC patients with CP.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how mitochondrial dysfunction restricts crypt fission in inflammatory bowel disease (IBD). Specifically, the researchers hypothesized that in patients with IBD, due to the low mitochondrial levels in intestinal epithelial cells (IECs) in the crypt, crypt fission is reduced during moderate to severe tissue inflammation, while this phenomenon is not obvious in patients with diverticulitis (DvC). The study aims to explore the impact of mitochondrial dysfunction on crypt fission in patients with IBD and its underlying mechanisms. ### Background - **Inflammatory bowel disease (IBD)**: IBD is a chronic disease, including Crohn's disease (CD) and ulcerative colitis (UC), characterized by continuous inflammatory responses in the intestine. - **Mitochondrial dysfunction**: Mitochondria are the power plants of cells, and their dysfunction is associated with various diseases, including IBD. - **Crypt fission**: The crypt is the regenerative unit of intestinal epithelial cells, and its fission is crucial for maintaining the normal renewal of the intestinal epithelium. ### Research objectives - **Explore the relationship between mitochondrial dysfunction and crypt fission**: The researchers hypothesized that in patients with IBD, mitochondrial dysfunction leads to a reduction in crypt fission, thereby affecting the repair and regeneration of the intestinal epithelium. - **Compare the crypt fission situations in patients with IBD and diverticulitis (DvC)**: By comparing the crypt fission situations in patients with IBD and DvC, further verify the impact of mitochondrial dysfunction on crypt fission. ### Methods - **Sample collection**: Tissue samples were collected from surgically resected specimens of patients with colonic diverticulitis (DvC), active Crohn's disease (CD), ulcerative colitis (UC), and unaffected colorectal cancer patients. - **Histological examination**: H&E staining was used to examine the crypt structure, branching, and fission, and the degree of inflammation was scored by a blinded pathologist. - **Immunohistochemical staining**: Immunohistochemical staining was performed using a marker for mitochondrial complex IV (MTCO1) to evaluate mitochondrial function. ### Results - **Number of crypt fissions**: In patients with diverticulitis (DvC), there were 4.778 ± 2.9 fission crypts per 100 crypts, while in patients with ulcerative colitis (UC) and Crohn's disease (CD), there were 3.469 ± 1.79 and 3.604 ± 1.3 fission crypts respectively. This indicates that the number of crypt fissions in DvC patients is 37.7% and 32.6% higher than that in UC and CD patients respectively. - **Mitochondrial function**: Immunohistochemical results showed that the expression of mitochondrial complex IV (MTCO1) in the crypts of UC and CD patients was significantly lower than that in DvC patients. ### Conclusions - **Mitochondrial dysfunction restricts crypt fission**: The research results support the hypothesis that mitochondrial dysfunction restricts crypt fission in patients with IBD. This may be an important reason for the decreased ability of intestinal epithelial repair in patients with IBD. - **Potential therapeutic targets**: Improving mitochondrial function may help promote crypt fission in patients with IBD, thereby improving the repair and regeneration of the intestinal epithelium. Through these studies, the authors hope to provide new ideas and potential therapeutic targets for the treatment of IBD.

MITOCHONDRIAL DYSFUNCTION CAUSES CECAL PATCH (CP) INFLAMMATION IN ULCERATIVE COLITIS

EPITHELIAL MITOCHONDRIAL DYSFUNCTION IN CHRONIC POUCHITIS

Sirtuin 1 Alleviates Endoplasmic Reticulum Stress-Mediated Apoptosis of Intestinal Epithelial Cells in Ulcerative Colitis.

MUCOSAL SINGLE-CELL PROFILING OF CROHN’S-LIKE DISEASE OF THE POUCH REVEALS COMMON PATHOGENICS AND THERAPEUTIC TARGETS

DOP41 Mucosal single-cell profiling of Crohn's-like disease of the pouch reveal unique pathogenesis and therapeutic targets

Mitochondrial dysfunction promotes microbial composition that negatively impacts on ulcerative colitis development and progression

Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets

Repressed Mitochondrial Function Limits Crypt Fissioning In Inflammatory Bowel Disease

S1440 The Cecal Patch in Ulcerative Proctitis – A Harbinger of Disease Progression or Merely an Incidental Finding?

Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment

Mucosal Single-Cell Profiling Of Crohn'S-Like Disease Of The Pouch Reveals Common Pathogenics And Therapeutic Targets

EPITHELIAL CELLS OF ULCERATIVE COLITIS PATIENTS REQUIRE NORMAL LEVELS OF MITOCHONDRIA AND BETA-CATENIN TO UTILIZE BUTYRATE METABOLISM AND PROMOTE ULCER HEALING

Mucosal cytokine expression associated with deep endoscopic mucosal healing in ulcerative colitis

Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease

Excessive Mitochondrial Fission Suppresses Mucosal Repair by Impairing Butyrate Metabolism in Colonocytes

Neutrophil-derived PAD4 induces citrullination of CKMT1 exacerbates mucosal inflammation in inflammatory bowel disease

Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.

Ileal Paneth Cell Phenotype is a Cellular Biomarker for Pouch Complications in Ulcerative Colitis

Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence

Mitochondrial dysfunction: unraveling the elusive biology behind anti-TNF response during ulcerative colitis

Stimulation-Induced Peripheral-Nerve Hyperemia - Mediation by Fibers Innervating Vasa-Nervorum